NorthStar Asset Management (New Jersey)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
NorthStar Asset Management (New Jersey)'s PFE Position: Q2 2026 in Review
NorthStar Asset Management (New Jersey) sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,316 shares — an estimated $234K sold.
NorthStar Asset Management (New Jersey) first reported a position in PFE in Q4 2023 and held it in 10 quarters. The position peaked at $351K in Q3 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- NorthStar Asset Management (New Jersey) reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- NorthStar Asset Management (New Jersey) sold 8,316 Pfizer shares in Q2 2026, an estimated $234K.
- NorthStar Asset Management (New Jersey) first reported a position in Pfizer in Q4 2023 and held it in 10 quarters.
- NorthStar Asset Management (New Jersey)'s Pfizer position peaked at $351K in Q3 2024.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q2 2026, filed 5 Aug 2026.